1. Home
  2. PRME vs SES Comparison

PRME vs SES Comparison

Compare PRME & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • SES
  • Stock Information
  • Founded
  • PRME 2019
  • SES 2012
  • Country
  • PRME United States
  • SES United States
  • Employees
  • PRME N/A
  • SES N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • SES Auto Parts:O.E.M.
  • Sector
  • PRME Health Care
  • SES Consumer Discretionary
  • Exchange
  • PRME Nasdaq
  • SES Nasdaq
  • Market Cap
  • PRME 379.1M
  • SES 367.8M
  • IPO Year
  • PRME 2022
  • SES N/A
  • Fundamental
  • Price
  • PRME $2.97
  • SES $0.89
  • Analyst Decision
  • PRME Strong Buy
  • SES Sell
  • Analyst Count
  • PRME 9
  • SES 2
  • Target Price
  • PRME $13.13
  • SES $1.25
  • AVG Volume (30 Days)
  • PRME 1.0M
  • SES 19.8M
  • Earning Date
  • PRME 03-04-2025
  • SES 02-25-2025
  • Dividend Yield
  • PRME N/A
  • SES N/A
  • EPS Growth
  • PRME N/A
  • SES N/A
  • EPS
  • PRME N/A
  • SES N/A
  • Revenue
  • PRME $800,000.00
  • SES N/A
  • Revenue This Year
  • PRME N/A
  • SES N/A
  • Revenue Next Year
  • PRME $477.62
  • SES N/A
  • P/E Ratio
  • PRME N/A
  • SES N/A
  • Revenue Growth
  • PRME N/A
  • SES N/A
  • 52 Week Low
  • PRME $2.25
  • SES $0.20
  • 52 Week High
  • PRME $9.77
  • SES $2.53
  • Technical
  • Relative Strength Index (RSI)
  • PRME 53.25
  • SES 41.01
  • Support Level
  • PRME $2.25
  • SES $0.93
  • Resistance Level
  • PRME $3.36
  • SES $1.35
  • Average True Range (ATR)
  • PRME 0.23
  • SES 0.11
  • MACD
  • PRME 0.07
  • SES -0.03
  • Stochastic Oscillator
  • PRME 64.41
  • SES 2.10

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About SES SES AI Corporation

SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.

Share on Social Networks: